Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 2, 2006 - Issue 1
Submit an article Journal homepage
405
Views
73
CrossRef citations to date
0
Altmetric
Review

High-throughput pKa screening and prediction amenable for ADME profiling

Hong Wan Senior Research Scientist, Associate Professor, AstraZeneca R&D Mlndal, DMPK & Bioanalytical Chemistry, S-43183 Mlndal, Sweden. [email protected]
&
Johan Ulander Senior Research Scientist, AstraZeneca R&D Mlndal, Medicinal Chemistry, S-43183 Mlndal, Sweden
Pages 139-155 | Published online: 01 Feb 2006

Bibliography

  • WELLS JI: Pharmaceutical Preformulation, 1st Ed. Eills Hoowood Ltd., London, UK (1998):25.
  • KIBBEY CE, POOLE SK, ROBINSON B, JACKSON JD, DURHAM D: An integrated process for measuring the physicochemical properties of drug candidates in a preclinical discovery environment. J. Pharm. Sci. (2001) 90:1164-1175.
  • KERNS EH, DI L: Physicochemical profiling: overview of the screens. Drug Discov. Today: Technologies (2004) 1:343-348.
  • ZHOU CX, JIN YK, KENSETH JR, STELLA M, WEHMEYER KR, HEINEMAN WR: Rapid pK(a) estimation using vacuum-assisted multiplexed capillary electrophoresis (VAMCE) with ultraviolet detection. J. Pharm. Sci. (2005) 94:576-589.
  • POOLE SK, PATEL S, DEHRING K, WORKMAN H, POOLE CF: Determination of acid dissociation constants by capillary electrophoresis. J. Chromatogr. A (2004) 1037:445-454.
  • JIA ZJ: Physicochemical profiling by capillary electrophoresis. Current Pharmaceutical Analysis (2005) 1:41-56.
  • MILLER JM, BLACKBURN AC, SHI Y, MELZAK AJ, ANDO OY: Semi-empirical relationships between effective mobility, charge, and molecular weight of pharmaceuticals by pressure-assisted capillary electrophoresis: applications in drug discovery. Electrophoresis (2002) 23:2833-2841.
  • JIA ZJ, RAMSTAD T, ZHONG M: Medium-throughput pKa screening of pharmaceuticals by pressure-assisted capillary electrophoresis. Electrophoresis (2001) 22:1112-1118.
  • WAN H, HOLMEN A, NAGARD M, LINDBERG W: Rapid screening of pKa values of pharmaceuticals by pressure-assisted capillary electrophoresis combined with short-end injection. J. Chromatogr. A (2002) 979:369-377.
  • ISHIHAMA Y, ODA Y, ASAKAWA NJ: Microscale determination of dissociation constants of multivalent pharmaceuticals by capillary electrophoresis. J. Pharm. Sci. (1994) 83:1500-1507.
  • PANG HM, KENSETH J, COLDIRONS: High-throughput multiplexed capillary electrophoresis in drug discovery. Drug Discov. Today (2004) 9:1072-1080.
  • WAN H, HOLMEN AG, WANG YD etal.: High-throughput screening of pKa values of pharmaceuticals by pressure-assisted capillary electrophoresis and mass spectrometry. Rapid Commun. Mass Spectrom. (2003) 17:2639-2648.
  • TAKACSNOVAK K, BOX KJ, AVDEEFA: Potentiometric pK(a) determination of water-insoluble compounds validation study in methanol/water mixtures. Int. J. Pharm. (1997) 151:235-248.
  • WAN H, THOMPSON RA: Capillary electrophoresis technologies for drug screening. Drug & Discovery Today: Technologies (2005) 2:171-178.
  • KALISZAN R, WICZLING P, MARKUSZEWSKI MJ: pH gradient high-performance liquid chromatography: theory and applications. J. Chromatogr. A (2004) 1060:165-175.
  • WICZLING P, MARKUSZEWSKI MJ, KALISZAN R: Determination of pK(a) by pH gradient reversed-phase HPLC. Anal. Chem. (2004) 76:3069-3077.
  • BOX K, BEVAN C, COMER J, HILL A, ALLEN R, REYNOLDS D: High-throughput measurement of pK(a) values in a mixed-buffer linear pH gradient system. Anal. Chem. (2003) 75:883-892.
  • TAM KY, TAKACS-NOVAK K: Multi-wavelength spectrophotometric determination of acid dissociation constants: a validation study. Analytica Chimica Acta (2001) 434:157-167.
  • KERNS EH: High throughput physicochemical profiling for drug discovery. J. Pharm. Sci. (2001) 90:1838-1858.
  • LIPINSKI CA: Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods. (2000) 22:235-249.
  • AVDEEF A: Absorption and Drug Development Solubility, Permeability and Charge State. John Wiley & Sons, Inc, Hobooken, New Jersey, US (2003):92.
  • AVDEEF A: Physicochemical profiling (solubility, permeability and charge state). Curr. Top. Med. Chem. (2001) 1:277-351.
  • ALBERTY RA: Effect of pH on proteinligand equilibria. J. Phys. Chem. B (2000) 104:9929-9934.
  • HINDERLING PH, HARTMANN D: The pH dependency of the binding of drugs to plasma proteins in man. Ther. Drug Monit. (2005) 27:71-85.
  • WAN H, REHNGREN M: High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry. J. Chromatogr. A (2005) 1102:125-134.
  • ERMONDI G, LORENTI M, CARON G: Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction. J. Med. Chem. (2004) 47:3949-3961.
  • LOMBARDO F, OBACH RS, SHALAEVA MY, GAO F: Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data. J. Med. Chem. (2002) 45:2867-2876.
  • YOSHIDA F, TOPLISS JG: QSAR model for drug human oral bioavailability. J. Med. Chem. (2000) 43:2575-2585.
  • OBATA K, SUGANO K, SAITOH R etal.: Prediction of oral drug absorption in humans by theoretical passive absorption model. Int. J. Pharm. (2005) 293:183-192.
  • LIN G, LIAO WC, CHAN CH, WU YH, TSAI HJ, HSIEH CW: Quantitative structureactivity relationships for the pre-steady state acetylcholinesterase inhibition by carbamates. J. Biochem. Mol. Toxicol. (2004) 18:353-360.
  • MCFARLAND JW, BERGER CM, FROSHAUER SA etal.: Quantitative structure-activity relationships among macrolide antibacterial agents invitro and invivo potency against pasteurella multocida. J. Med. Chem. (1997) 40:1340-1346.
  • CARLING RW, LEESON PD, MOOREKW etal.: 4-Substituted-3-phenylquinolin-2(1h)-ones acidic and nonacidic glycine site N-methyl-d-aspartate antagonists with invivo activity. J. Med. Chem. (1997) 40:754-765.
  • ZHAO YH, JI GD, CRONIN MTD, DEARDEN JC: QSAR study of the toxicity of benzoic acids to vibrio fischeri, daphnia magna and carp. Sci. Total Environ. (1998) 216:205-215.
  • MORIDANI MY, SIRAKI A, OBRIENPJ: Quantitative structure toxicity relationships for phenols in isolated rat hepatocytes. Chem. Biol. Interact. (2003) 145:213-223.
  • ODOU P, BARTHELEMY C, ROBERTH: Development of midazolam sublingual tablets invitro study. Eur. J. Drug Metab. Pharmacokinet. (1998) 23:87-91.
  • PALM K, LUTHMAN K, ROS J, GRASJOJ, ARTURSSON P: Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. J. Pharmacol. Exp. Ther. (1999) 291:435-443.
  • NAGAHARA N, TAVELIN S, ARTURSSON P: Contribution of the paracellular route to the pH-dependent epithelial permeability to cationic drugs. J. Pharm. Sci. (2004) 93:2972-2984.
  • TAKAHASHI K, SAKANO H, RYTTINGJH, NUMATA N, KURODAS, MIZUNO N: Influence of pH on the permeability of p-toluidine and aminopyrine through shed snake skin as a model membrane. Drug Dev. Ind. Pharm. (2001) 27:159-164.
  • AVDEEF A, ARTURSSON P, NEUHOFFS, LAZOROVA L, GRASJO J, TAVELIN S: Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA pK(a)(flux) method. Eur. J. Pharm. Sci. (2005) 24:333-349.
  • RUELL JA, TSINMAN KL, AVDEEF A: PAMPA a drug absorption invitro model 5. Unstirred water layer in iso-pH mapping assays and pK(a)(flux) optimized design (pOD-PAMPA). Eur. J. Pharm. Sci. (2003) 20:393-402.
  • DOHERTY MM, PANG KS: First-pass effect significance of the intestine for absorption and metabolism. Drug Chem. Toxicol. (1997) 20:329-344.
  • RILEY RJ, PARKER AJ, TRIGG S, MANNERS CN: Development of a generalized, quantitative physicochemical model of CYP3A4 inhibition for use in early drug discovery. Pharma. Res. (2001) 18:652-655.
  • UPTHAGROVE AL, NELSON WL: Importance of amine pK(a) and distribution coefficient in the metabolism of fluorinated propranolol derivatives. Preparation, identification of metabolite regioisomers, and metabolism by CYP2D6. Drug Metab. Dispos. (2001) 29:1377-1388.
  • VASHISHTHA SC, HAWES EM, MCCANN DJ, GHOSHEH O, HOGG L: Quaternary ammonium-linked glucuronidation of 1-substituted imidazoles by liver microsomes: interspecies differences and structure-metabolism relationships. Drug Metab. Dispos. (2002) 30:1070-1076.
  • LEWIS DFV: Human cytochromes P450 associated with the phase I metabolism of drugs and other xenobioties: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families. Curr. Med. Chem. (2003) 10:1955-1972.
  • BONATE PL, REITH K, WEIR S: Drug interactions at the renal level implications for drug development. Clin. Pharmacokinet. (1998) 34:375-404.
  • MARTIN YC: A bioavailability score. J. Med. Chem. (2005) 48:3164-3170.
  • HINE J: Structural Effects on Equilibria in Organic Chemistry. Wiley, New York, US (1975).
  • WELLS PR: Linear Free Energy Relationships. Academic Press, New York, US (1968).
  • HANSCH C, HOEKMAN D, GAO H: Comparative QSAR toward a deeper understanding of chemicobiological interactions. Chem. Rev. (1996) 96:1045-1075.
  • HANSCH C, TAFT RW: A survey of hammet substituent constants and resonance and field parameters. Chem. Rev. (1991):165-195.
  • CHIPMAN DM: Computation of pK(a) from dielectric continuum theory. J. Phys. Chem. (2002) 106:7413-7422.
  • LIPTAK MD, SHIELDS GC: Accurate pK(a) calculations for carboxylic acids using Complete Basis Set and Gaussian-n models combined with CPCM continuum solvation methods. J. Am. Chem. Soc. (2001) 123:7314-7319.
  • ULANDER J, BROO A: On the use of empirical correction terms in the calculation of ionization constants. Int. J. Quantum Chem. (2005).
  • JAGUAR: JAGUAR v4.0 Manual. Schroedinger, Inc, Portland, OR, USA.
  • WARSHEL A, VILLA J, SHURKI A, HONG G, STRAJBL M, FLORIAN J: Pushing the frontiers of QM/MM methods for studies of energetics and dynamics in large systems. Abstr. Pap. Am. Chem. Soc. (2001) 222:COMP10.
  • WARSHEL A, LEVITT M: Theoretical studies of enzymic reactions: Dielectric, electrostatic and steric stabilization of the carbonium ion in the reaction of lysozyme. J. Mol. Biol. (1976) 103:249.
  • MONGAN J, CASE DA, MCCAMMONJA: Constant pH molecular dynamics in generalized born implicit solvent. J. Comput. Chem. (2004) 25:2038-2048.
  • SANDBERG L, EDHOLM O: pK(a) calculations along a bacteriorhodopsin molecular dynamics trajectory. Biophys. Chem. (1997) 65:189-204.
  • ULLMANN GM, NOODLEMAN L, CASE DA: Density functional calculation of pK(a) values and redox potentials in the bovine Rieske iron-sulfur protein. J. Biol. Inorg. Chem. (2002) 7:632-639.
  • PODLOGAR BL, MUEGGE I, BRICE LJ: Computational methods to estimate drug development parameters. Curr. Opin. Drug Discov. Devel. (2001) 4:102-109.
  • LI H, ROBERTSON AD, JENSEN JH: The determinants of carboxyl pK(a) values in Turkey ovomucoid third domain. Proteins Structure Function & Bioinformatics (2004) 55:689-704.
  • ALMERINDO GI, TONDO DW, PLIEGO JR: Ionization of organic acids in dimethyl sulfoxide solution: a theoretical ab initio calculation of the pK(a) using a new parametrization of the polarizable continuum model. J. Phys. Chem. A Mol. Spectrosc. Kinet. Environ. Gen. Theory (2004) 108:166-171.
  • KUHN B, KOLLMAN PA, STAHL M: Prediction of pK(a) shifts in proteins using a combination of molecular mechanical and continuum solvent calculations. J. Comput. Chem. (2004) 25:1865-1872.
  • MA YG, GROSS KC, HOLLINGSWORTH CA, SEYBOLDPG, MURRAY JS: Relationships between aqueous acidities and computed surfaceelectrostatic potentials and local ionization energies of substituted phenols and benzoic acids. J. Mol. Model. (2004) 10:235-239.
  • KORENAGA T, KADOWAKI K, EMA T, SAKAI T: Reestimation of the Tafts substituent constant of the pentafluorophenyl group. J. Org. Chem. (2004) 69:7340-7343.
  • SIMONSON T, CARLSSON J, CASE DA: Proton binding to proteins: pK(a) calculations with explicit and implicit solvent models. J. Am. Chem. Soc. (2004) 126:4167-4180.
  • KAMINSKI GA: Accurate prediction of absolute acidity constants in water with a polarizable force field: substituted phenols, methanol, and imidazole. J. Phys. Chem. B (2005) 109:5884-5890.
  • PICKARD FC, POKON EK, LIPTAKMD, SHIELDS GC: Comparison of CBS-QB3, CBS-APNO, G2 and G3 thermochemical predictions with experiment for formation of ionic clusters of hydronium and hydroxide ions complexed with water. J. Chem. Phys. (2005) 122:24302.
  • PLIEGO JR, RIVEROS JM: Theoretical calculation of pK(a) using the cluster-continuum model. J. Phys. Chem. (2002) 106:7434-7439.
  • JANG YH, GODDARD WA, NOYES KT, SOWERS LC, HWANG S, CHUNG DS: pK(a) values of guanine in water: density functional theory calculations combined with PoissonBoltzmann continuum-solvation model. J. Phys. Chem. B (2003) 107:344-357.
  • KLAMT A, ECKERT F, DIEDENHOFENM, BECK ME: First principles calculations of aqueous pK(a) values for organic and inorganic acids using COSMO-RS reveal an inconsistency in the slope of the pK(a) scale. J. Phys. Chem. A Mol. Spectrosc. Kinet. Environ. Gen. Theory (2003) 107:9380-9386.
  • LIPTAK MD, GROSS KC, SEYBOLDPG, FELDGUS S, SHIELDSGC: Absolute pK(a) determinations for substituted phenols. J. Am. Chem. Soc. (2002) 124:6421-6427.
  • KLICIC JJ, FRIESNER RA, LIU SY, GUIDA WC: Accurate prediction of acidity constants in aqueous solution via density functional theory and self-consistent reaction field methods. J. Phys. Chem. (2002) 106:1327-1335.
  • HOLLINGSWORTH CA, SEYBOLDPG, HADAD CM: Substituent effects on the electronic structure and pK(a) of benzoic acid. Int. J. Quantum Chem. (2002) 90:1396-1403.
  • JANG YH, GODDARD WA, NOYES KT, SOWERS LC, HWANG S, CHUNG DS: First principles calculations of the tautomers and pK(a) values of 8-oxoguanine: Implications for mutagenicity and repair. Chem. Res. Toxicol. (2002) 15:1023-1035.
  • LIPTAK MD, SHIELDS GC: Experimentation with different thermodynamic cycles used for pK(a) calculations on carboxylic acids using complete basis set and gaussian-n models combined with CPCM continuum solvation methods. Int. J. Quantum Chem. (2001) 85:727-741.
  • GROSS KC, SEYBOLD PG: Substituent effects on the physical properties and pK(a) of phenol. Int. J. Quantum Chem. (2001) 85:569-579.
  • CITRA MJ: Estimating the pKa of phenols, carboxylic acids and alcohols from semi-empirical quantum chemical methods. Chemosphere (1999) 38:206.
  • ABRAHAM RJ, GRIFFITHS L, LOFTUSP: Approaches to charge calculations in molecular mechanics. J. Comput. Chem. (1982) 9:407-416.
  • DIXON SL, JURS PC: Estimation of pK(a) for organic oxyacids using calculated atomic charges. J. Comput. Chem. (1993) 14:1460-1467.
  • HEMMATEENEJAD B, SAFARPOURMA, TAGHAVI F: Application of ab initio theory for the prediction of acidity constants of some 1-hydroxy-9,10-anthraquinone derivatives using genetic neural network. Theochem J. Mol. Struct. (2003) 635:183-190.
  • KHANDOGIN J, YORK DM: Quantum descriptors for biological macromolecules from linear-scaling electronic structure methods. Proteins Structure Function & Bioinformatics (2004) 56:724-737.
  • VERMA RP, KURUP A, HANSCH C: On the role of polarizability in QSAR. Bioorg. Med. Chem. (2005) 13:237-255.
  • ULANDER J, HAYMET ADJ: Permeation across hydrated DPPC lipid bilayers: simulation of the titrable amphiphilic drug valproic acid. Biophys. J. (2003) 85:3475-3484.
  • KESSEL A, MUSAFIA B, BEN-TAL N: Continuum solvent model studies of the interactions of an anticonvulsant drug with a lipid bilayer. Biophys. J. (2001) 80:2536-2545.
  • SANDBERG L, EDHOLM O: A fast and simple method to calculate protonation states in proteins. Proteins (1999) 36:474-483.
  • SCHUTZ CN, WARSHEL A: What are the dielectric constants of proteins and how to validate electrostatic models? Proteins: Structure, Function, & Genetics (2001) 44:400-417.
  • SIMONSON T: Macromolecular electrostatics: continuum models and their growing pains. Curr. Opin. Struct. Biol. (2001) 11:243-252.
  • SORIANO E, CERDAN S, BALLESTEROS P: Computational determination of pK(a) values. A comparison of different theoretical approaches and a novel procedure. Theochem-J. Mol. Struct. (2004) 684:121-128.
  • NIELSEN JE, MCCAMMON JA: Calculating pKa values in enzyme active sites. Protein Sci. (2003) 12:1894-1901.
  • NIELSEN JE, MCCAMMON JA: On the evaluation and optimization of protein X-ray structures for pKa calculations. Protein Sci. (2003) 12:313-326.
  • ACD: Advanced Chemistry Development software v. 7.07. edn Advanced Chemistry Development software v. 7.07. Edited by: Advanced Chemistry Development software v. 7.07.
  • HILAL SH, ELSHABRAWY Y, CARREIRA LA, KARICKHOFF SW, TOUBAR SS, RIZK M: Estimation of the ionization pK(a) of pharmaceutical substances using the computer program sparc. Talanta (1996) 43:607-619.
  • GROSS KC, SEYBOLD PG: Substituent effects on the physical properties and pK(a) of aniline. Int. J. Quantum Chem. (2000) 80:1107-1115.
  • GROSS KC, SEYBOLD PG, PERALTA-INGA Z, MURRAY JS, POLITZER P: Comparison of quantum chemical parameters and Hammett constants in correlating pK(a) values of substituted anilines. J. Org. Chem. (2001) 66:6919-6925.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.